Relationships between resistance to cisplatin and antifolates in sensitive and resistant tumour cell lines
- 30 June 1995
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (6) , 981-986
- https://doi.org/10.1016/0959-8049(95)00198-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell linesBritish Journal of Cancer, 1995
- Effects of a new antioestrogen, idoxifene, on cisplatin- and doxorubicin-sensitive and -resistant human ovarian carcinoma cell linesBritish Journal of Cancer, 1994
- Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.Journal of Clinical Oncology, 1993
- In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatinBritish Journal of Cancer, 1993
- Ovarian cancer: new clinical approachesCancer Treatment Reviews, 1991
- Characteristics of five human tumor cell lines and sublines resistant to cis‐diamminedichloroplatinum(II)International Journal of Cancer, 1991
- Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexesBritish Journal of Cancer, 1989
- Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells.Proceedings of the National Academy of Sciences, 1988
- Mechanisms of cross-resistance to methotrexate and 5-fluorouracil in an A2780 human ovarian carcinoma cell subline resistant to cisplatinBiochemical Pharmacology, 1988
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984